BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6855796)

  • 1. Myasthenia gravis immunoglobulin augments motor neuron survival without producing muscle paralysis.
    Sohal GS; Leshner RT; Swift TR
    Muscle Nerve; 1983 Feb; 6(2):122-7. PubMed ID: 6855796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of reduced neuron pool on the magnitude of naturally occurring motor neuron death.
    Sohal GS; Stoney SD; Arumugam T; Yamashita T; Knox TS
    J Comp Neurol; 1986 May; 247(4):516-28. PubMed ID: 3722449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of grafting a smaller target muscle on the magnitude of naturally occurring trochlear motor neuron death during development.
    Sohal GS; Stoney SD; Campbell LR; Arumugam T; Kumaresan K; Hirano S
    J Comp Neurol; 1991 Feb; 304(2):187-97. PubMed ID: 2016416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of target size in neuronal survival.
    Sohal GS
    J Neurobiol; 1992 Nov; 23(9):1124-30. PubMed ID: 1469379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the trochlear nucleus in quail and comparative study of the trochlear nucleus, nerve, and innervation of the superior oblique muscle in quail, chick, and duck.
    Sohal GS; Knox TS; Allen JC; Arumugam T; Campbell LR; Yamashita T
    J Comp Neurol; 1985 Sep; 239(2):227-36. PubMed ID: 4044937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of trochlear motor neurons, superior oblique muscle, and neuromuscular junctions following prevention of cell death by myasthenia gravis immunoglobulin.
    Sohal GS; Swift TR
    Int J Dev Neurosci; 1985; 3(5):573-82. PubMed ID: 24874967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in acetylcholine receptor number correlated with increased naturally occurring trochlear motor neuron death during development.
    Boydston WR; Sohal GS
    Exp Neurol; 1983 Mar; 79(3):801-7. PubMed ID: 6825764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of altered afferent input on the number of trochlear motor neurons during development.
    Sohal GS; Hirano S; Kumaresan K; Ali MM
    J Neurobiol; 1992 Feb; 23(1):10-6. PubMed ID: 1564452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
    Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
    Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of myasthenic immunoglobulin on ACh receptors of cultured muscle.
    Drachman DB; Kao L; Angus CW; Murphy A
    Trans Am Neurol Assoc; 1977; 102():96-100. PubMed ID: 616125
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased motor neuron projection during development does not increase the number of neuromuscular synapses.
    Sohal GS; Arumugam T; Swift TR
    Exp Neurol; 1986 Apr; 92(1):284-8. PubMed ID: 3956656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of myasthenic patient sera on the number and distribution of acetylcholine receptors in muscle and nerve-muscle cultures from rat. Correlations with clinical state.
    Eymard B; de la Porte S; Pannier C; Berrih-Aknin S; Morel E; Fardeau M; Bach JF; Koenig J
    J Neurol Sci; 1988 Aug; 86(1):41-59. PubMed ID: 3171596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera (author's transl)].
    Morel E; Raimond F; Goulon-Goëau C; Berrih S; Vernet-Der-Garabedian B; Harb J; Bach JF
    Nouv Presse Med; 1982 May; 11(24):1849-54. PubMed ID: 7110933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
    Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
    Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis.
    Strober J; Cowan MJ; Horn BN
    Arch Neurol; 2009 May; 66(5):659-61. PubMed ID: 19433668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophins promote motor neuron survival and are present in embryonic limb bud.
    Henderson CE; Camu W; Mettling C; Gouin A; Poulsen K; Karihaloo M; Rullamas J; Evans T; McMahon SB; Armanini MP
    Nature; 1993 May; 363(6426):266-70. PubMed ID: 8487864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Seronegative" anti-MUSK positive myasthenia gravis presenting during pregnancy.
    Terrero A; Ramírez-Rivera J
    Bol Asoc Med P R; 2006; 98(3):210-2. PubMed ID: 19610560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis.
    Vincent A; Solleveld HA
    Clin Exp Immunol; 1981 Jan; 43(1):94-8. PubMed ID: 7249398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.